徐州妇产科在线-【徐州瑞博医院】,徐州瑞博医院,徐州要怎么预约做四维彩超,徐州四维彩照需要多长时间,徐州什么时候四维b超,徐州几个月以后可以照四维,徐州哪个医院做四维彩超,徐州医院内镜检查多少钱

BEIJING, Sept. 6 (Xinhuanet) -- A short-term memory loss may suggest the Alzheimer's disease, according to a new study made by Spanish researchers.The finding was published on Monday, in Archives of General Psychiatry, an American Medical Association journal.The researchers gathered data of 116 people with mild cognitive impairment (MCI) who developed Alzheimer's disease within two years, 204 patients with the condition who didn't develop Alzheimer's and 197 people with no cognitive problems.Mild cognitive impairment is usually marked by difficulties with short-term memory, such as losing your train of thought repeatedly or having trouble remembering what you did yesterday, according to the study.After assessing them by biomarker tests and cognitive measures, the researcher found the cognitive markers can forecast the variance."Remarkably, they accounted for nearly 50% of the predictive variance," said Dr. Gomar of Centro de Investigation Biomedica en Red de Salud Mental, Barcelona, who led the research.Mild cognitive impairment at the start of the study was a stronger predictor of Alzheimer's than most biomarkers, the researchers concluded.
BEIJING, Aug 4 (Xinhuanet) – A new urine test might help doctors detect prostate cancer and better evaluate a patient's treatment options, according to American reseachers Thursday."This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision," said lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System.The test looks for two genetic markers associated with prostate cancer. The first, called TMPRSS2:ERG, is caused by two genes changing places and fusing together; it is thought to cause prostate cancer. Since the gene fusion is only seen in about half of cancer patients, the test also looks for another marker, called PCA3."We are exploiting some new bio-markers to try to refine the PSA (prostate-specific antigen) test," Tomlins said.

SAN FRANCISCO, June 22 (Xinhua) -- Apple Inc. plans to introduce a new iPhone in September featuring faster chip and more advanced camera, U.S. media reported on Wednesday.The new iPhone model, which will closely resemble iPhone 4, will include the A5 processor, a more powerful chip that Apple added to the iPad 2 tablet computer earlier this year, along with an 8-megapixel camera, up from the 5-megapixel model in the iPhone 4, Bloomberg quoted two people familiar with the product as saying.The device will run the iOS 5 operating system Apple previewed at its annual developer conference earlier this month.Aiming at attracting customers in developing countries, Apple is also working to finish a cheaper version of the iPhone which will use chips and displays of similar quality to the current iPhone 4, said the sources.Meanwhile, it was reported that Apple is also testing a new version of the iPad with a higher resolution screen, which, similar to the one currently used on iPhone 4, will be about one- third higher than iPad 2 and feature a more responsive touchscreen.According to a recent projection on smartphone market by the International Data Corp. (IDC), a small market share decline of iPhone is expected as the smartphone market matures and diversifies in 2011.The release of a new iPhone would help Apple gain more market share as smartphones powered by Google's Android system are predicted to grow to more than 40 percent of the market in the second half of this year.
BEIJING, Sept. 14 (Xinhuanet) -- The U.S. Food and Drug Administration (FDA) on Monday announced a recall on a drug infusion pump of Medtronic, the Associated Press reported.The recalled drug pump was called "SynchroMed II", including models of 8637-20 and 8637-40, distributed between 2004 and July 2011.Drug infusion pump was used to deliver the drugs for patients to treat chronic pain, spasms as well as other conditions.The pumps' malfunction could put patients in the risk of either recurrent or withdrawal symptoms, which could be life-threatening, FDA warned.There were 55 reported cases and one death related to the drug withdrawal, among a total 139,653 SynchroMed II pump implants worldwide, FDA notified.The problem was due to a film within the pump's battery that could stop the therapy, FDA said.Medtronic, the U.S. medical technology company based in Minneapolis, is not recommending patients to remove the pumps, but instead, encourage patients to contact their doctor if they hear the device alarm.
WASHINGTON, July 5 (Xinhua) -- The countdown for the final space shuttle launch began Tuesday afternoon, but unfavorable weather may delay shuttle Atlantis' launch attempt on Friday, NASA announced."We are going with a 60 percent chance of KSC (Kennedy Space Center) weather prohibiting launch due to the potential for showers and isolated thunderstorms in the area," shuttle weather officer Kathy Winters told reporters Tuesday at a precountdown status briefing. "I wish I had a better weather briefing for you."Atlantis is scheduled to lift off at 11:26 am (1526 GMT) on Friday from Kennedy Space Center with four U.S. astronauts on board for a 12-day mission to the International Space Station. Overall, the chance of an on-time liftoff is 40 percent, Winters said."We will do everything we can to launch on Friday but if things don't work out so that we can do that we have plenty of options... Saturday and Sunday," said NASA Test Director Jeremy Graeber. Conditions improve for Atlantis launch opportunities on Saturday and Sunday.NASA said it must launch Atlantis by Sunday, otherwise it will have to wait until at least July 16. That's because of an unmanned rocket due to lift off next week, using the same launch support personnel and equipment.NASA's 30-year-old shuttle program is ending due to high operating costs. The Obama administration wants to spur private companies to get into the space taxi business, freeing NASA to focus on deep space exploration and new technology development.When the U.S. space shuttle program officially ends later this year, the Russian space program's Soyuz capsule will be the only method for transporting astronauts to and from the station.
来源:资阳报